Claus Vogelmeier
- Pulmonary and Respiratory Medicine top 0.01%
- Chronic Obstructive Pulmonary Disease (COPD) Research 320
- Respiratory Support and Mechanisms 131
- Respiratory and Cough-Related Research 68
- Pulmonary Hypertension Research and Treatments 41
- Inhalation and Respiratory Drug Delivery 39
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 31
- Issues, ethics and legal aspects top 0.05%
- Physiology top 0.05%
- Asthma and respiratory diseases 175
- Emergency Medical Services top 0.05%
- Microbiology top 0.2%
-
- Protease and Inhibitor Mechanisms 32
- Co-authors
- Àlvar AgustíLeonardo M. FabbriJørgen VestboFernando J. MartínezPaul JonesRoberto Rodríguez-RoisinAntonio AnzuetoRobert A. Stockley
- Journals
- European Respiratory Journal (37 papers)International Journal of COPD (37 papers)Respiratory Medicine (32 papers)
- Partner nations
- GermanyUnited StatesUnited Kingdom
In The Last Decade
Claus Vogelmeier
473 papers receiving 25.4k citations
Hit Papers
Peers
Comparison fields: 5 of 183
- Pulmonary and Respiratory Medicine 18.9k
- Issues, ethics and legal aspects 589
- Physiology 9.8k
- Emergency Medical Services 1.6k
- Microbiology 1.3k
Countries citing papers authored by Claus Vogelmeier
This map shows the geographic impact of Claus Vogelmeier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claus Vogelmeier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claus Vogelmeier more than expected).
Fields of papers citing papers by Claus Vogelmeier
This network shows the impact of papers produced by Claus Vogelmeier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claus Vogelmeier. The network helps show where Claus Vogelmeier may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Claus Vogelmeier, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2026 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 5 | |
| 4 | 2025 | 1 | |
| 5 | 2025 | 0 | |
| 6 | 2025 | 0 | |
| 7 | 2024 | 0 | |
| 8 | 2024 | 1 | |
| 9 | 2024 | 1 | |
| 10 | 2024 | 3 | |
| 11 | 2024 | 1 | |
| 12 | 2023 | 13 | |
| 13 | 2023 | 1 | |
| 14 | 2022 | 16 | |
| 15 | Interclass Difference in Pneumonia Risk in COPD Patients Initiating Fixed Dose Inhaled Treatment Containing Extrafine Particle Beclometasone versus Fine Particle Fluticasone | 2022 | 6 |
| 16 | 2019 | 1 | |
| 17 | 2013 | 1 | |
| 18 | 2013 | 6 | |
| 19 | 2013 | 1 | |
| 20 | 2010 | 25 |
About Claus Vogelmeier
Claus Vogelmeier is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Issues, ethics and legal aspects, having authored 515 papers that have together received 26.2k indexed citations. Recurring topics across this work include Chronic Obstructive Pulmonary Disease (COPD) Research (320 papers), Asthma and respiratory diseases (175 papers), Respiratory Support and Mechanisms (131 papers), Respiratory and Cough-Related Research (68 papers), Pulmonary Hypertension Research and Treatments (41 papers), Inhalation and Respiratory Drug Delivery (39 papers), Protease and Inhibitor Mechanisms (32 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (31 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (18.9k citations), Issues, ethics and legal aspects (589 citations) and Physiology (9.8k citations). Claus Vogelmeier has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Àlvar Agustí, Leonardo M. Fabbri, Jørgen Vestbo, Fernando J. Martínez, Paul Jones, Roberto Rodríguez-Roisin, Antonio Anzueto, Robert A. Stockley, Don D. Sin and Suzanne S. Hurd. Their work appears in journals such as European Respiratory Journal, International Journal of COPD, Respiratory Medicine, Respiratory Research and American Journal of Respiratory and Critical Care Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.